TAKEDA PHARMACEUTICAL CO LTD 13D and 13G filings for Day One Biopharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-03 5:06 pm Sale | 2022-06-21 | 13G | Day One Biopharmaceuticals, Inc. DAWN | TAKEDA PHARMACEUTICAL CO LTD | 0 0.000% | -6,012,758 (Position Closed) | Filing |
| 2023-02-03 11:50 am Unchanged | 2022-06-21 | 13G | Day One Biopharmaceuticals, Inc. DAWN | TAKEDA PHARMACEUTICAL CO LTD | 0 0.000% | 0 (Unchanged) | Filing |
| 2022-01-14 06:02 am Purchase | 2021-12-31 | 13G | Day One Biopharmaceuticals, Inc. DAWN | TAKEDA PHARMACEUTICAL CO LTD | 6,012,758 9.700% | 6,012,758 (New Position) | Filing |